PCMC
GSK icon

Planning Capital Management Corporation’s GSK GSK Stock Holding History

Planning Capital Management Corporation’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$54.1K Sell
1,323
-648
-33% -$26.5K 0.04% 168
2024
Q2 		$75.9K Hold
1,971
– – 0.05% 161
2024
Q1 		$84.5K Hold
1,971
– – 0.06% 144
2023
Q4 		$73K Buy
+1,971
New +$70.8K 0.06% 159

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Planning Capital Management Corporation's GSK Position: Q3 2024 in Review

Planning Capital Management Corporation reduced its GSK (GSK) stake by 33% in Q3 2024, selling an estimated $26.5K and leaving 1,323 shares worth $54.1K. The position accounts for 0.04% of the portfolio, ranked #168.

Planning Capital Management Corporation first reported a position in GSK in Q4 2023 and has held it in 4 quarters since. The position peaked at $84.5K in Q1 2024. 900 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • Planning Capital Management Corporation held 1,323 shares of GSK worth $54.1K as of Q3 2024.
  • Planning Capital Management Corporation sold 648 GSK shares in Q3 2024, an estimated $26.5K.
  • GSK made up 0.04% of Planning Capital Management Corporation's portfolio in Q3 2024, its #168 holding.
  • Planning Capital Management Corporation first reported a position in GSK in Q4 2023 and has held it in 4 quarters since.
  • Planning Capital Management Corporation's GSK position peaked at $84.5K in Q1 2024.
  • 900 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.